Actively Recruiting
Evaluating New Treatment Strategies for Patients with Incurable Cancer Using an Evolutionary Tumor Board
Led by H. Lee Moffitt Cancer Center and Research Institute · Updated on 2026-04-01
35
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the ability of a multidisciplinary team called the Evolutionary Tumor Board ETB to develop new therapeutic strategies for patients with cancer who have no curative treatment options. This observational study focuses on participants considered likely incurable under standard care, including those in remission but at high risk of recurrence or with suboptimal responses to previous therapies. The ETB includes experts such as evolutionary biologists, mathematicians, statisticians, radiologists, pathologists, and various oncologists. Participants clinical histories, imaging, pathology, and available treatment options are reviewed by the ETB. The team generates hypotheses, mathematical models, and experimental ideas to suggest additional evolutionary-based therapeutic strategies. Data regarding adherence to and outcomes from ETB recommendations are collected through chart reviews. Participants will be followed over time, allowing ongoing collection of clinical information including scans and blood samples. Researchers will measure the ETBs ability to create therapeutic strategies from baseline up to 60 months after therapy ends. This long-term follow-up helps evaluate how the ETBs recommendations may impact treatment planning and patient care over time.
CONDITIONS
Brief Title
Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board
Research Team
S
Sara Donadelli
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here